Drug History: SEREVENT

DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST

Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Label and Approval History

Drug Name:	SEREVENT
FDA Application No:	(NDA) 020236
Active Ingredient(s):	SALMETEROL XINAFOATE
Company:	GLAXOSMITHKLINE

Label History

View the label approved on October 4, 2004 for SEREVENT, (NDA) 020236

To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.

Approval History

Action Date	Supplement Number	Approval Type	Letters, Reviews, Labels, Patient Package Insert
9/28/2004	030	Labeling Revision	Letter Label
8/11/2003	028	Labeling Revision	Letter Label
10/16/2001	025	Control Supplement
5/17/2001	023	Labeling Revision
6/15/2000	021	Control Supplement
6/29/2000	019	Efficacy Supplement with Clinical Data to Support
2/25/2000	018	Labeling Revision
12/24/1998	017	Labeling Revision	Review
5/11/1998	016	Labeling Revision
2/5/1998	015	New or Modified Indication
11/26/1997	014	Labeling Revision
8/6/1996	013	Manufacturing Change or Addition
11/13/1995	011	Control Supplement
7/19/1995	010	Control Supplement
12/23/1994	009	Labeling Revision
3/14/1995	008	Control Supplement
12/23/1994	006	Control Supplement
10/15/1996	003	Control Supplement
7/9/1996	001	Labeling Revision
2/4/1994	000	Approval	Other Important Information from FDA

There are no Therapeutic Equivalents